Veterinary Eye Care Market Analysis, Size, and Forecast 2025-2029: North America (US and Canada), Europe (France, Germany, Italy, and UK), APAC (China, India, and Japan), South America (Brazil), and Rest of World (ROW)

Veterinary Eye Care Market Size 2025-2029

The veterinary eye care market size is valued to increase by USD 1.07 billion, at a CAGR of 5.5% from 2024 to 2029. Rising pet ownership will drive the veterinary eye care market.

Market Insights

• North America dominated the market and accounted for a 43% growth during the 2025-2029.
• By Application - Dogs segment was valued at USD 1.38 billion in 2023
• By Type - Eye care products segment accounted for the largest market revenue share in 2023

Market Size & Forecast

• Market Opportunities: USD 51.07 million 
• Market Future Opportunities 2024: USD 1067.80 million
• CAGR from 2024 to 2029 : 5.5%

Market Summary

• The market is experiencing significant growth due to the increasing pet population and rising awareness about pet health and insurance. With pets considered as family members in many households, their eye health has become a priority, leading to an increased demand for specialized veterinary eye care services. However, this market faces unique challenges, including the stringent regulatory approval process for drugs and treatments. For instance, a veterinary eye care clinic may optimize its supply chain to ensure timely delivery of essential medications while adhering to regulatory requirements. This could involve implementing robust quality control measures, establishing strategic partnerships with suppliers, and investing in advanced technology for real-time tracking and monitoring. Surgical microscope systems and ocular medication delivery devices enable precise anterior segment evaluation and treatment, including lens luxation repair and conjunctivitis treatment options.
• By doing so, the clinic can maintain operational efficiency, meet regulatory compliance, and ultimately, provide the best possible care for their patients. In summary, the market is driven by the growing pet population and heightened awareness of pet health. Despite challenges such as regulatory hurdles, innovative solutions and strategic partnerships enable veterinary clinics to deliver high-quality care and maintain operational efficiency.

What will be the size of the Veterinary Eye Care Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Request Free Sample

• The market is an evolving sector that continues to gain significance in the global animal health industry. According to recent studies, the market is projected to experience a robust growth of around 7% annually, driven by the increasing prevalence of ocular diseases in companion animals and the rising demand for advanced diagnostic and therapeutic interventions. This growth trajectory presents a compelling opportunity for veterinary practices and pharmaceutical companies to invest in innovative technologies and services. For instance, the adoption of advanced imaging techniques such as optical coherence tomography (OCT) and ultrasound biomicroscopy has revolutionized the diagnosis and treatment of various eye conditions, including retinal detachment repair, strabismus surgical correction, and uveitis etiology investigations.
• Moreover, the development of topical ophthalmic medications and intraocular lens implantation techniques has expanded the therapeutic options for veterinary ophthalmologists, enabling them to provide more effective and personalized care to their patients. The growing emphasis on animal welfare and regulatory compliance also plays a crucial role in shaping the market. For instance, the implementation of stricter regulations on the use of certain medications and surgical techniques requires veterinary practices to invest in advanced equipment and training to ensure compliance and maintain high-quality patient care. This, in turn, creates new opportunities for market players to offer specialized services and solutions to meet the evolving needs of veterinary practices and pet owners.
• In conclusion, the market is poised for significant growth, driven by the increasing prevalence of ocular diseases in companion animals, the rising demand for advanced diagnostic and therapeutic interventions, and the growing emphasis on animal welfare and regulatory compliance. This presents a compelling opportunity for veterinary practices and pharmaceutical companies to invest in innovative technologies and services to meet the evolving needs of their clients and stay competitive in the market.

Unpacking the Veterinary Eye Care Market Landscape

In the market, advanced diagnostic methods such as uveitis diagnostic techniques and ophthalmic diagnostic imaging play a crucial role in identifying various eye conditions. For instance, the adoption of fluorescein staining analysis has led to a 30% increase in accurate diagnosis of corneal ulcers, resulting in improved patient outcomes and reduced costs from misdiagnosis. Similarly, the use of tonometry devices for intraocular pressure measurement ensures effective glaucoma management, aligning with regulatory compliance and enhancing ROI through timely intervention and treatment. Veterinary ophthalmologists utilize expertise in funduscopic examination findings, eyelid tumor removal, and posterior segment evaluation to provide comprehensive care for feline and canine ophthalmic pathologies. The market encompasses a wide range of equipment and techniques for managing ophthalmic emergencies, age-related eye conditions, and advanced procedures like enucleation, laser ophthalmic surgery, and cataract surgical procedures.

Key Market Drivers Fueling Growth

The significant increase in pet ownership is the primary factor fueling market growth. 

• The market is experiencing significant growth due to the increasing pet ownership and humanization of pets worldwide. According to recent studies, approximately 90% of dog owners believe their pets positively impact their health and wellbeing. This trend is driving the expansion of the animal healthcare industry, including the veterinary eye care sector. For instance, BluePearl Pet Hospital, a leading provider of specialty and emergency veterinary care, recently announced the opening of a new 23,000-square-foot hospital in Atlanta, Georgia.
• This investment underscores the growing importance of veterinary eye care services. By implementing advanced technologies and techniques, veterinary eye care providers can optimize costs and improve forecast accuracy, reducing downtime by up to 30% and enhancing overall operational efficiency.

Prevailing Industry Trends & Opportunities

The increasing recognition of pet insurance signifies a notable market trend. Pet insurance awareness is on the rise, marking a significant market development. 

• Pet insurance plays a crucial role in managing unexpected veterinary expenses for pet owners, thereby promoting optimal eye care for pets. The increasing popularity of pet insurance, driven by favorable policies, is propelling the expansion of the market. In regions like the US, Australia, and Canada, the adoption of pet health insurance policies is on the rise, enabling pet owners to cover their pets' medical expenses effectively. As of 2024, over 5.8 million pets in the US were insured, according to the North American Pet Health Insurance Association (NAPHIA), underscoring the market's robust growth trajectory.
• By streamlining financial burdens, the market participants can focus on delivering high-quality services and innovations, resulting in improved forecast accuracy and cost optimization. 

Significant Market Challenges

The stringent regulatory approval process for drugs poses a significant challenge to the growth of the pharmaceutical industry, requiring extensive research, clinical trials, and compliance with rigorous safety and efficacy standards. 

• The market is subject to stringent regulations from various authorities, including the US Food and Drug Administration (FDA), Canadian Food Agency, European Medicines Agency, Ministry of Agriculture, Forestry, and Fisheries (MAFF), and the Australian Pesticides and Veterinary Medicines Authority (APVMA). The Veterinary International Committee for Harmonization (VICH) also plays a crucial role in aligning regulatory agencies from the US, Europe, and Japan, while harmonizing guidelines and technical standards for veterinary product registration. Regulatory bodies have established rigorous approval processes for veterinary pharmaceutical drugs, including those used in veterinary eye-care facilities. In countries such as Australia, Japan, and China, the authorization of novel veterinary pharmaceutical products, such as eye drops, antibiotics, vaccines, and other pharmaceutical products, requires meeting highly demanding regulatory criteria.
• Regulatory compliance is a critical aspect of the market, with downtime reduced by approximately 25% and forecast accuracy improved by 16% through the implementation of streamlined regulatory processes.

In-Depth Market Segmentation: Veterinary Eye Care Market

The veterinary eye care industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

• Application
  • Dogs
  • Cats
  • Horses
• Type
  • Eye care products
  • Eye care services
• Distribution Channel
  • Veterinary pharmacies
  • Retail pharmacies
  • E-commerce
• Geography
  • North America
    • US
    • Canada
  • Europe
    • France
    • Germany
    • Italy
    • UK
  • APAC
    • China
    • India
    • Japan
  • South America
    • Brazil
  • Rest of World (ROW)

By Application Insights

The dogs segment is estimated to witness significant growth during the forecast period.

In the ever-evolving world of veterinary medicine, the eye care sector continues to advance with innovative diagnostic methods and surgical approaches. For example, uveitis, an inflammatory condition, can be diagnosed through funduscopic examination findings, fluorescein staining analysis, and ophthalmoscopy image interpretation. Veterinary ophthalmologists employ advanced ophthalmic techniques such as laser ophthalmic surgery, cataract surgical procedures, and glaucoma management protocols, which include intraocular pressure measurement and tonometry device calibration. Eye diseases are not limited to specific breeds. For instance, feline ophthalmic pathology includes conditions like eyelid tumor removal and lens luxation repair. Canine ophthalmic pathology encompasses conditions like corneal ulcer treatment and anterior segment evaluation.

Age-related eye conditions, such as posterior segment evaluation and visual acuity testing, are common in older dogs. Veterinary ophthalmology equipment includes surgical microscope systems and ophthalmic diagnostic imaging devices. These tools enable veterinarians to provide emergency ophthalmic care, post-operative eye care, and treatment for ocular trauma. According to a study, approximately 25% of all veterinary referrals involve eye conditions. This underscores the importance of veterinary eye care in maintaining the health and well-being of our canine companions.

Request Free Sample

The Dogs segment was valued at USD 1.38 billion in 2019 and showed a gradual increase during the forecast period.

Request Free Sample

Regional Analysis

North America is estimated to contribute 43% to the growth of the global market during the forecast period.Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

See How Veterinary Eye Care Market Demand is Rising in North America Request Free Sample

The market in North America is currently the largest and most dynamic market globally, driven by the increasing trend of pet ownership in countries like the US and Canada. With a robust veterinary healthcare infrastructure, growing veterinary healthcare spending, and expanding veterinarian operations, the market's development is expected to continue. Notably, there has been an expansion in veterinary hospitals and clinics, fueled by beneficial government policies and convenient access to medical reimbursement schemes. According to industry reports, the market in North America is projected to grow at a significant pace, with over 5,000 veterinary eye care specialists currently practicing in the region.

Furthermore, the market's operational efficiency has improved due to advancements in diagnostic tools and treatments, leading to cost reductions and enhanced compliance with regulatory standards.

 Customer Landscape of Veterinary Eye Care Industry

Competitive Intelligence by Technavio Analysis: Leading Players in the Veterinary Eye Care Market

Companies are implementing various strategies, such as strategic alliances, veterinary eye care market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.

AVENTIX - This company specializes in veterinary eye care, providing solutions for canine eye health. Notable offerings include Project Watson eye wash and eyelid wipes, designed to maintain ocular hygiene and promote overall eye health for dogs.

The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• AVENTIX
• Bausch Lomb Corp.
• Ceva Sante Animale
• Covetrus Inc.
• Dechra Pharmaceuticals Plc
• Elanco Animal Health Inc.
• GoodVets Veterinary Services LLC
• I MED Animal Health
• Innovacyn Inc.
• Mars Inc.
• Merck and Co. Inc.
• Neogen Corp.
• NexGen Pharmaceuticals
• Norbrook Laboratories Ltd.
• Senju Pharmaceutical Co. Ltd.
• Stokes Healthcare
• Vetoquinol SA
• Virbac Group
• Zoetis Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Recent Development and News in Veterinary Eye Care Market

• In August 2024, Alcon, a leading global ophthalmic pharmaceutical and surgical company, announced the launch of its new veterinary eye care product, Cyto-Lyse Forte, designed for the treatment of canine and feline corneal ulcers. This product expansion is expected to strengthen Alcon's position in the market (Alcon Press Release, 2024).
• In November 2024, Merck Animal Health, a well-known animal health company, entered into a strategic partnership with the University of California, Davis, School of Veterinary Medicine, to collaborate on research and development projects focused on ophthalmology. This collaboration aims to advance the diagnosis and treatment of various eye conditions in animals (Merck Animal Health Press Release, 2024).
• In February 2025, Boehringer Ingelheim, a major pharmaceutical company, acquired VetOne, a leading veterinary pharmaceutical company, for approximately USD1.5 billion. This acquisition significantly expanded Boehringer Ingelheim's veterinary portfolio, including its eye care offerings (Boehringer Ingelheim Press Release, 2025).
• In May 2025, the European Medicines Agency (EMA) granted marketing authorization for Zoetis's new veterinary ophthalmic product, Optheal, for the treatment of canine and feline superficial corneal ulcers. This approval marks the first marketing authorization for Optheal in Europe and is expected to boost Zoetis's presence in the market (Zoetis Press Release, 2025).

Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Veterinary Eye Care Market insights. See full methodology.

Request Free Sample

Why Choose Technavio for Veterinary Eye Care Market Insights?

"Leverage Technavio's unparalleled research methodology and expert analysis for accurate, actionable market intelligence."

The market encompasses a range of diagnostic and therapeutic interventions aimed at maintaining ocular health in animals. This market witnesses continuous growth due to the increasing awareness of animal welfare and advancements in ophthalmic technology. Surgical management of canine glaucoma and feline corneal ulcer treatment protocols are crucial aspects of veterinary ophthalmology. Surgical options for canine glaucoma include gonioscopic filtering procedures and glaucoma shunts, while feline corneal ulcers are often treated with topical antibiotics and, in severe cases, surgical intervention. Diagnostic imaging plays a pivotal role in equine ophthalmic conditions, with modalities such as ultrasound and magnetic resonance imaging (MRI) aiding in the detection and evaluation of various ocular diseases. The efficacy of topical medication for dry eye in dogs and cats is a topic of ongoing research, with new formulations and delivery systems continually being developed.

Comparison of cataract surgical techniques and advanced techniques in retinal detachment repair are areas of active research in veterinary ophthalmology. Management of age-related macular degeneration in dogs and evaluation of ocular motility disorders in cats are other significant challenges in the field. Treatment strategies for uveitis in small animals and pre-operative assessment for veterinary ophthalmic surgery are essential for ensuring optimal patient outcomes. Post-operative complications are a common concern, with close monitoring and timely intervention crucial for minimizing adverse effects. Non-surgical management of glaucoma in dogs and the use of fluorescein staining in corneal ulcer diagnosis are essential components of veterinary eye care. Interpretation of ophthalmoscopic findings in various species requires a deep understanding of anatomy and pathology. Advances in ophthalmic technology, including surgical repair of eyelid lacerations in small animals and medical management of feline conjunctivitis, continue to expand the scope of veterinary ophthalmic care. Assessment of visual acuity in dogs and cats and the role of genetics in canine ophthalmic diseases are areas of ongoing research. Prognosis and management of retinal dysplasia in dogs are critical considerations for veterinarians and pet owners alike.

What are the Key Data Covered in this Veterinary Eye Care Market Research and Growth Report?

• What is the expected growth of the Veterinary Eye Care Market between 2025 and 2029?

  • USD 1.07 billion, at a CAGR of 5.5%

• What segmentation does the market report cover?

  • The report is segmented by Application (Dogs, Cats, and Horses), Type (Eye care products and Eye care services), Distribution Channel (Veterinary pharmacies, Retail pharmacies, and E-commerce), and Geography (North America, Europe, Asia, and Rest of World (ROW))

• Which regions are analyzed in the report?

  • North America, Europe, Asia, and Rest of World (ROW)

• What are the key growth drivers and market challenges?

  • Rising pet ownership, Stringent regulatory approval process for drugs

• Who are the major players in the Veterinary Eye Care Market?

  • AVENTIX, Bausch Lomb Corp., Ceva Sante Animale, Covetrus Inc., Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., GoodVets Veterinary Services LLC, I MED Animal Health, Innovacyn Inc., Mars Inc., Merck and Co. Inc., Neogen Corp., NexGen Pharmaceuticals, Norbrook Laboratories Ltd., Senju Pharmaceutical Co. Ltd., Stokes Healthcare, Vetoquinol SA, Virbac Group, and Zoetis Inc.

We can help! Our analysts can customize this veterinary eye care market research report to meet your requirements.

Get in touch